Biotechnology patenting takes off in developing countries

International Journal of Biotechnology

Volumn 8, Issue 1-2, 2006, Pages 43-59

  Quach, Uyen ^a   Thorsteinsdóttir, Halla ^a,b   Renihan, James ^a   Bhatt, Archana ^a,b   Costa Von Aesch, Zoë ^a,c   Singer, Peter A ^a,b,d,e,f   Daar, Abdallah S ^a,b,g,h  

^a UNIVERSITY OF TORONTO   (Canada)

^b Canadian Program on Genomics and Global Health   (Canada)

^c QUEEN S UNIVERSITY   (Canada)

^d at the University of Toronto Wagner is also a faculty member of the Canadian Medical Associations' Physician Management Institute   (Canada)

^e UNIVERSITY HEALTH NETWORK   (Canada)

^f CANADIAN INSTITUTES OF HEALTH RESEARCH   (Canada)

^g McLaughlin Centre for Molecular Medicine   (Canada)

^h High Level Africa Biotechnology Panel   (Canada)

Author keywords

Biotechnology; Brazil; China; Cuba; Developing countries; Egypt; India; Innovation; Intellectual property; South Africa; South Korea; South South; Technological change; TRIPS

Indexed keywords

DATABASE SYSTEMS; DEVELOPING COUNTRIES; PATENTS AND INVENTIONS; TECHNOLOGY TRANSFER;

BRAZIL; INNOVATION; SOUTH AFRICA; TECHNOLOGICAL CHANGE;

BIOTECHNOLOGY;

BIOTECHNOLOGY; DEVELOPING WORLD; INNOVATION;

ARTICLE; BIOTECHNOLOGY; DATA BASE; DEVELOPING COUNTRY; INDUSTRY; MEDICAL RESEARCH; ORGANIZATION AND MANAGEMENT; PATENT;

HARNESS;

EID: 33644893626     PISSN: 09636048     EISSN: None     Source Type: Journal    
DOI: 10.1504/ijbt.2006.008963     Document Type: Article

References (42)

1. Abdelgafar, B. (2004) 'The emergence of health biotechnology in Egypt: public commitment and personal ingenuity', Prepared for the Canadian Program on Genomics and Global Health, University of Toronto Joint Centre for Bioethics.
2. Abdelgafar, B., Thorsteinsdóttir, H., Quach, U., Singer, P.A. and Daar, A.S. (2004) The emergence of health biotechnology in Egypt from generics', Insight, Nature Biotechnology Vol. 22, Suppl., pp.DC25-DC30.
3. Archambault, E. (2002) 'Patents in cross-country comparisons', Scientometrics, Vol. 54, pp.15-30.
4. Cortright, J. and Mayer, H. (2002) Signs of Life: The Growth of Biotechnology Centers in the U.S., Washington, DC: The Brookings Institution Center on Urban and Metropolitan Policy.
5. Daar, A.S., Thorsteinsdóttir, H., Martin, D.K., Smith, A.C., Nast, S. and Singer, P.A. (2002) 'Top 10 biotechnologies for improving health in developing countries', Nature Genetics, Vol. 32, No. 2, pp.229-232.
6. da Motta e Albuquerque, E. (2000) 'Domestic patents and developing countries: arguments for their study and data from Brazil (1980-1995)', Research Policy, Vol. 29, pp.1047-1060.
7. Demis, H. and Guellec, D. (2001) 'Using patent counts for cross-country comparisons of technology output', STI Review, Vol. 27, pp.129-146.
8. FAO (2002) 'The state of food and agriculture: agricultural biotechnology meeting the needs of the poor', Report.
9. Ferrer, M., Thorsteinsdóttir, H., Quach, U., Singer, P.A. and Daar, A.S. (2004) The scientific muscle of Brazil's health biotechnology', Nature Biotechnology, Vol. 22, Suppl., pp.DC37-DC41.
10. Gupta, R.K. and Balasubrahmanyam, L. (1998) 'The tumeric effect', World Patent Information, Vol. 20, pp.185-191.
11. Heller, M.A. and Eisenberg, R.S. (1998) 'Can patents deter innovation: the anticommons in biomedical research', Science, Vol. 280, No. 5364, pp.698-701.
12. Hirshhorn, R. and Langford, J. (2001) 'Intellectual property rights in biotechnology: the economic argument', Prepared for The Canadian Biotechnology Advisory Committee Project Steering Committee on Intellectual Property and the Patenting of Higher Life Forms.
13. International Diabetes Foundation, WHO (2004) 'Diabetes action now', Report.
14. Jaffe, A.B. and Lerner, J. (2004) Innovation and Its Discontents: How Our Broken Patent System is Endangering Innovation and Progress, and What to Do About It, New Jersey: Princeton University Press.
15. Jayaraman, K.S. (2003) 'India budgets for boost in research', Nature, Vol. 422, p.6.
16. Kumar, N.K., Quach, U., Thorsteinsdóttir, H. and Somsekhar, H. (2004) 'Indian biotechnology - rapidly evolving and industry led', Nature Biotechnology, Vol. 22, Suppl., pp.DC31-DC36.
17. Lall, S. (2003) 'Indicators of the relative importance of IPRs in developing countries', Research Policy, Vol. 32, pp.1657-1680.
18. Lanjouw, J.O. and Cockburn, I.M. (2001) 'World development', Vol. 29, pp.265-289.
19. Motari, M., Quach, U., Thorsteinsdóttir, H., Martin, D.K., Daar, A.S. and Singer, P.A. (2004) 'South Africa - blazin a trail for African biotechnology', Nature Biotechnology, Vol. 22, Suppl., pp.DC37-DC41.
20. Niosi, J. (2003) 'Alliances are not enough explaining rapid growth in biotechnology firms', Research Policy, Vol. 32, pp.737-750.
21. OECD (2001) 'Brazil, China and India share knowledge strategies: a unique policy conference', Report.
22. OECD (2003) 'Turning science into business, in patenting and licensing at public research organizations', Report.
23. OECD (2004a) 'Biotechnology for sustainable growth and development, in meeting of the OECD committee for scientific and technological policy at ministerial level', Report.
24. OECD (2004b) 'Patents and innovation: trends and policy challenges', Report.
25. Saha, R., Satyanarayana, K. and Gardner, C.A. (2004) 'Building a 'cottage industry' for health (and wealth): the new framework for IP management in India', IP Strategy Today, Vol. 10, pp.23-61.
26. Sawahel, W. (2004) 'GM maize could produce Hepatitis B vaccine', SciDev.net, 7 April.
27. Thomas, S.M., Birtwistle, N., Brady, M. and Burke, J.F. (1997) 'Public-sector patents on human DNA', Nature, Vol. 388, p.709.
28. Thorsteinsdóttir, H., Archambault, É., Arunachalam, S., Daar, A.S. and Singer, P. (2006) 'Health biotechnology publishing takes-off in developing countries', International Journal of Biotechnology, Vol. X, No. Y, pp.XXX-XXX.
29. Thorsteinsdóttir, H., Quach, U., Daar, A.S. and Singer, P.A. (2004a) 'Conclusions: promoting biotechnology innovation in developing countries', Nature Biotechnology, Vol. 22, Suppl., pp.DC48-DC52.
30. Thorsteinsdóttir, H., Quach, U., Martin, D.K., Daar, A.S. and Singer, P.A. (2004b) 'Introduction: promoting global health through biotechnology', Insight. Nature Biotechnology, Vol. 22, Suppl., pp.DC3-DC7.
31. Thorsteinsdóttir, H., et al. (2004e) 'Cuba - innovation through synergy', Nature Biotechnology, Vol. 22, Suppl., pp.DC19-DC24.
32. Timmerman, K. (2003) 'Intellectual property rights and traditional medicine: policy dilemmas at the interface', Social Science and Medicine, Vol. 57, pp.745-756.
33. UNAIDS and WHO (2003) 'AIDS epidemic update', Report.
34. UNCTAD (2002) 'Key issues in biotechnology', Report.
35. UNCTAD (2004) The biotechnology promise: capacity-building for participation of developing countries in the bioeconomy', Report.
36. WHO (2002a) 'Diet, physical activity and health. Prepared by the secretariat', In Fifty-Fifth World Health Assembly, Provisional Agenda Item 13.11.A55/16, Report.
37. WHO (2002b) 'Hepatitis C Fact sheet', Report.
38. WHO (2003a) 'Cancer fact sheet', Report.
39. WHO (2003b) 'Country profile: India, in global tuberculosis control', Report.
40. Wong, J. (2004) 'Health biotechnology in South Korea: a new industrial paradigm', Prepared for the Canadian Program on Genomics and Global Health, University of Toronto Joint Centre for Bioethics.
41. Wong, J., Quach, U., Thorsteinsdóttir, H., Singer, P.A. and Daar, A.S. (2004) 'South Korean biotechnology - a rising industrial and scientific powerhouse', Nature Biotechnology, Vol. 22, Suppl., pp.DC42-DC48.
42. Zhenzhen, L., Jiuchun, Z., Ke, W., Thorsteinsdóttir, H., Quach, U., Singer, P.A. and Daar, A.S. (2004) 'Health biotechnology in China - reawakening of a giant', Nature Biotechnology, Vol. 22, Suppl., pp.DC13-DC18.